IMMUNE RESPONSE DRUG CONJUGATES: CARBON-14 LABELING NECESSITIES
Journal Title: Journal of Drug Discovery and Therapeutics - Year 2013, Vol 1, Issue 6
Abstract
Despite recent advances in early detection and treatment, prostate cancer is the most common cancer and the second leading cause of cancer-related deaths in developed countries. Prostate cancer patients having a limited number of treatment options such as radiotherapy, cytotoxic chemotherapy etc. Although results of all approaches are showing beneficial effects, but without long term survival benefit. A recent development in the field of cancer treatment named as gene therapy comes in existence with promise of prostate cancer treatment. It is an emerging field against not only prostate cancer but for all types of cancers. With advancement of basic research and gene therapy technology, no doubt it may be the best future cancer treatment with the use of genetic engineering and clinical trials. In this review we tried to conclude the importance of the gene therapy in prostate cancer with novel and unique characteristics and with promise to cure as the hope for management of the prostate cancer.
Authors and Affiliations
Pramod Singh Khatri| PhD. Scholar, Department of Pediatrics, AIIMS Hospital, India.
Keywords
Related Articles
- EP ID EP1411
- DOI -
- Views 462
- Downloads 29
BIODATA, RESUME & CURRICULUM VITAE: PAST BEHAVIOUR IS THE BEST PREDICTOR OF FUTURE BEHAVIOUR FOR CROSSING MILESTONES
All your life you have been subtly passing the question around when it came to actual differentiation among the three - Biodata, CV and Resume, isn't it? Although all of them fall under the same broad spectrum, but there...
Wound healing activity of the ethanolic extract of Solanum spirale leaves indigenous to north east India
As a part of present work objective are to investigate indigenous plant used in wound healing in northeast India, we hereby reported our findings related to wound healing activities of plant Solanum spirale (Solanaceae)...
FORMULATION AND EVALUATION OF RIFAMPICIN SOLID LIPID NANOPARTICLES
The solid lipid nanoparticles (SLNs) are sub-micron sized colloidal carriers composed of physiological lipid dispersed either in water or in an aqueous surfactant solution. SLNs as colloidal drug carrier combine the adv...
FDA'S NEW DRUG REVIEW PROCESS: AN OVERVIEW FROM OFFICIAL WEBSITE
Drugs are the vital and inevitable part of modern day treatment strategies. Drugs are always directly related with lives of human beings. There should be very strict approval process before getting permission for their m...
MARKET SURVEY OF ANTITUBERCULOSIS DRUGS IN INDIA
Tuberculosis (TB) is a contagious disease. It is worldwide occurring disease affecting millions of people. A WHO report in 2011 show that almost 8.7 million people is in apprehension of Tuberculosis. Tuberculosis commonl...